Breast-conserving therapy may be a treatment option for some patients with multiple breast lesions

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainPatients with multiple tumors in the same breast who underwent a lumpectomy followed by radiation therapy had local re

Updated on: December 19,2023 10

Breast-conserving therapy may be a treatment option for some patients with multiple breast lesions

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainPatients with multiple tumors in the same breast who underwent a lumpectomy followed by radiation therapy had local re

Updated on:December 19,2023 10

Fertility preservation measures do not appear to increase the risk of breast cancer recurrence

byKarolinska InstitutetCancer-Specific Survival in the Cohort. FP indicates fertility preservation. Credit:JAMA OncologyDOI: 10.1001/jamaoncol.2022.3677Women with a breast cancer dia

Updated on: December 19,2023 9

Fertility preservation measures do not appear to increase the risk of breast cancer recurrence

byKarolinska InstitutetCancer-Specific Survival in the Cohort. FP indicates fertility preservation. Credit:JAMA OncologyDOI: 10.1001/jamaoncol.2022.3677Women with a breast cancer dia

Updated on:December 19,2023 9

Low long-term risk of breast cancer recurrence after nipple-sparing mastectomy

byWolters Kluwer HealthCredit: Pixabay/CC0 Public DomainNipple-sparing mastectomy (NSM)—an increasingly popular option for women undergoing treatment for breast cancer—not only achieves good cos

Updated on: December 19,2023 10

Low long-term risk of breast cancer recurrence after nipple-sparing mastectomy

byWolters Kluwer HealthCredit: Pixabay/CC0 Public DomainNipple-sparing mastectomy (NSM)—an increasingly popular option for women undergoing treatment for breast cancer—not only achieves good cos

Updated on:December 19,2023 10

Protective mutation shown to impair esophagus tumor growth

byWellcome Trust Sanger InstituteDifferentiation and homeostasis in aged Notch1 mutant mouse tissue. a, YFPCreNotch1flox/floxmice were induced at high dose so mutant cells rapidly covered

Updated on: December 19,2023 15

Protective mutation shown to impair esophagus tumor growth

byWellcome Trust Sanger InstituteDifferentiation and homeostasis in aged Notch1 mutant mouse tissue. a, YFPCreNotch1flox/floxmice were induced at high dose so mutant cells rapidly covered

Updated on:December 19,2023 15

Blood Stem Cell Mutations Exacerbate Colon Cancer Growth

byColleen Fleisson August 26, 2023Certaincolon cancersmay experience accelerated growth due to typical age-related alterations in the blood system, said University of Florida C

Updated on: December 19,2023 31

Blood Stem Cell Mutations Exacerbate Colon Cancer Growth

byColleen Fleisson August 26, 2023Certaincolon cancersmay experience accelerated growth due to typical age-related alterations in the blood system, said University of Florida C

Updated on:December 19,2023 31

How does obesity cause cancer?

Overweight and obesity is the second biggest cause of cancer in the UK – causing more than 1 in 20 cancer cases.The risk is higher the more overweight you are and the longer you are overweight for.Kee

Updated on: December 19,2023 16

How does obesity cause cancer?

Overweight and obesity is the second biggest cause of cancer in the UK – causing more than 1 in 20 cancer cases.The risk is higher the more overweight you are and the longer you are overweight for.Kee

Updated on:December 19,2023 16

Noninvasive Test Shows Promise in Early Bladder Cancer Diagnosis

byColleen Fleisson August 15, 2023A new molecular diagnostic method that identifies primary bladder cancer in patients who observe blood in their urine (hematuria) could expediteblad

Updated on: December 19,2023 23

Noninvasive Test Shows Promise in Early Bladder Cancer Diagnosis

byColleen Fleisson August 15, 2023A new molecular diagnostic method that identifies primary bladder cancer in patients who observe blood in their urine (hematuria) could expediteblad

Updated on:December 19,2023 23

Progression-free survival increased with zanubrutinib in leukemia

by Elana Gotkine HealthDay ReporterProgression-free survival is significantly longer with zanubrutinib than ibrutinib among patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or s

Updated on: December 19,2023 12

Progression-free survival increased with zanubrutinib in leukemia

by Elana Gotkine HealthDay ReporterProgression-free survival is significantly longer with zanubrutinib than ibrutinib among patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or s

Updated on:December 19,2023 12

Less chemotherapy better for older or frail patients with advanced stomach and oesophageal cancers

byCancer Research UK| News15 May 2019Less chemotherapy is as effective at controlling disease for elderly or frail patients with advanced cancer of the stomach or oesophagus (food pipe), a

Updated on: December 19,2023 19

Less chemotherapy better for older or frail patients with advanced stomach and oesophageal cancers

byCancer Research UK| News15 May 2019Less chemotherapy is as effective at controlling disease for elderly or frail patients with advanced cancer of the stomach or oesophagus (food pipe), a

Updated on:December 19,2023 19

Study opens door to targeted treatments for oesophageal cancer

byCancer Research UK| News5 September 2016Scientists have discovered thatoesophageal cancercan be classified into three different subtypes, paving the way for testing targeted

Updated on: December 19,2023 26

Study opens door to targeted treatments for oesophageal cancer

byCancer Research UK| News5 September 2016Scientists have discovered thatoesophageal cancercan be classified into three different subtypes, paving the way for testing targeted

Updated on:December 19,2023 26

Targeted therapy momelotinib provides significant symptom and anemia improvements in patients with myelofibrosis

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainPatients with myelofibrosis had clinically significant improvement in disease-related symptoms, including anem

Updated on: December 19,2023 10

Targeted therapy momelotinib provides significant symptom and anemia improvements in patients with myelofibrosis

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainPatients with myelofibrosis had clinically significant improvement in disease-related symptoms, including anem

Updated on:December 19,2023 10

Targeting cancer-supporting cells boosts immunotherapy in previously insensitive tumors

byInstitute of Cancer ResearchHuman breast cancer cells implanted in an experimental animal with two different tracers (red and blue) to investigate the interaction of tumour cells. Credit:&nbsp

Updated on: December 19,2023 12

Targeting cancer-supporting cells boosts immunotherapy in previously insensitive tumors

byInstitute of Cancer ResearchHuman breast cancer cells implanted in an experimental animal with two different tracers (red and blue) to investigate the interaction of tumour cells. Credit:&nbsp

Updated on:December 19,2023 12